Skip to main content
Log in

Emerging Role of Sirolimus in the Treatment of Diffuse Venous Malformation in a Woman with Klippel-Trenaunay Syndrome

  • Letter to the Editor
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136(1):203–14.

    Article  Google Scholar 

  2. Tee AR, Blenis J. mTOR, translational control and human disease. Semin Cell Dev Biol. 2005;16(1):29–37.

    Article  CAS  Google Scholar 

  3. Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018–24.

    Article  Google Scholar 

  4. Ventura-Aguiar P, Campistol JM, Diekmann F. Safety of mTOR inhibitors in adult solid organ transplantation. Expert Opin Drug Saf. 2016;15(3):303–19.

    Article  CAS  Google Scholar 

  5. Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M, et al. Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review. J Vasc Surg. 2020;71(1):318–27.

    Article  Google Scholar 

Download references

Acknowledgements

For their editorial assistance, we thank Jenni Weems, MS, Kerry Kennedy, BA, and Rachel Box, MS, in the Editorial Services group of The Johns Hopkins Department of Orthopaedic Surgery.

Funding

This study was supported wholly by NIH T32 Institutional Training Grant T32EB006351-12. The funding body was not involved in the design of the study, collection/analysis/interpretation of the data, or the writing of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clifford R. Weiss.

Ethics declarations

Conflict of interest

C.R.W. is funded by BTG, Siemens, and Medtronic and is a consultant for BTG and Medtronic (all unrelated to this study). The remaining authors have nothing to disclose.

Consent for Publication

Consent for publication was obtained for every individual person’s data included in the study.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional review board approval was waived for this study.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

SIR Annual Scientific Meeting: This has been accepted by SIR as an educational abstract for the 2021 SIR Annual Scientific Meeting.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, F., Bailey, C.R., Khalil, A. et al. Emerging Role of Sirolimus in the Treatment of Diffuse Venous Malformation in a Woman with Klippel-Trenaunay Syndrome. Cardiovasc Intervent Radiol 44, 1672–1674 (2021). https://doi.org/10.1007/s00270-021-02902-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-021-02902-5

Navigation